毛颖佳;郑源强;石艳春;

• 1:内蒙古医学院分子生物学研究中心

摘要(Abstract)：

与其他载体相比,慢病毒载体具有携带基因片段容量大、转染效率高、可感染分裂细胞及非分裂细胞、目的基因可在宿主细胞中长时间稳定表达以及安全性好等诸多优点,现已成为转移目的基因的理想载体。本文主要就慢病毒载体及其在基因治疗、生物医药与科学研究等领域的研究进展作一综述。

关键词(KeyWords)： 慢病毒载体;基因治疗

Abstract:

Keywords:

基金项目(Foundation): 教育部“春晖计划”(Z2007-1-01004);; 内蒙古医学院重大项目(NY2006ZD005)

作者(Authors): 毛颖佳;郑源强;石艳春;

DOI: 10.13200/j.cjb.2009.02.97.maoyj.010

参考文献(References)：

• [1]Aris K,Michael T,Oliver G,et al.Discovery and analysis of the first endogenous lentivirus.PNAS,2007,104(15):6261-6265.
• [2]Parolin C,Sodroski J.A defective HIV-1vector for gene transfer to human lymphocytes.J Mol Med,1995,73(6):279-288.
• [3]Curran MA,Kaiser SM,Achacoso PL,et al.Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors.Mol Ther,2000,1(1):31-38.
• [4]Mitrophanous K,Yoon S,Rohll J,et al.Stable gene transfer to the nervous system using a non-primate lentiviral vector.Gene Ther,1999,6(11):1808-1818.
• [5]Mselli-Lakhal L,Favier C,Da Silva Teixeira MF,et al.Defective RNA packaging is responsible for low transduction efficiency of CAEV-based vectors.Arch Virol,1998,143(4):681-695.
• [6]Berkowitz R,Ilves H,Lin WY,et al.Construction and molecular analysis of gene transfer systems derived from bovine immunodefi-ciency virus.J Virol,2001,75(7):3371-3382.
• [7]Berkowitz RD,Ilves H,Plavec I,et al.Gene transfer systems de-rived from Visna virus:analysis of virus production and infectivity.Virology,2001,279(1):116-129.
• [8]Poeschla EM.Non-primate lentiviral vectors.Curr Opin Mol Ther,2003,5(5):529-540.
• [9]Cockrell AS,Kafri T.Gene delivery by lentivirus vectors.Mol Biotechnol,2007,36(3):184-204.
• [10]Sumimoto H,Kawakami Y.Lentiviral vector-mediated RNAi and its use for cancer research.Future Oncol,2007,3(6):655-664.
• [11]Liau SS,Ashley SW,Whang EE.Lentivirus-mediated RNA inter-ference of HMGA1promotes chemosensitivity to gemcitabine in pancreatic adenocarcinoma.J Gastrointest Surg,2006,10(9):1254-1263.
• [12]Siming X,Weiyi F,Zhen L.Lentivirus-mediated RNAi silencing targeting ABCC2increasing the sensitivity of a human nasopha-ryngeal carcinoma cell line against cisplatin.J Transl Med,2008,6(1):55-63.
• [13]Bardella C,Dettori D,Olivero M,et al.The therapeutic potential of hepatocyte growth factor to sensitize ovarian cancer cells to cisplatin and paclitaxel in vivo.Clin Cancer Res,2007,13(7):2191-2198.
• [14]Kock N,Kasmieh R,Weissleder R,et al.Tumor therapy mediated by lentiviral expression of shBcl-2and S-TRAIL.Neoplasia,2007,9(5):435-442.
• [15]Bobisse S,Zanovello P,Rosato A.T-cell receptor gene transfer by lentiviral vectors in adoptive cell therapy.Expert Opin Biol Ther,2007,7(6):893-906.
• [16]Yang S,Rosenberg SA,Morgan RA.Clinical-scale lentiviral vec-tor transduction of PBL for TCR gene therapy and potential for expression in less-differentiated cells.Immunother,2008,31(9):830-839.
• [17]Breckpot K,Aerts JL,Thielemans K.Lentiviral vectors for cancer immunotherapy:transforming infectious particles into therapeu-tics.Gene Ther,2007,14(11):847-862.
• [18]Morris KV,Rossi JJ.Anti-HIV-1gene expressing lentiviral vec-tors as an adjunctive therapy for HIV-1infection.Curr HIV Res,2004,2(2):185-191.
• [19]Morris KV,Rossi JJ.Lentiviral-mediated delivery of siRNAs for antiviral therapy.Gene Ther,2006,13(6):553-558.
• [20]Joseph A,Zheng JH,Follenzi A,et al.Lentiviral vectors encoding human immunodeficiency virus type1(HIV-1)-specific T-cell re-ceptor genes efficiently convert peripheral blood CD8T lympho-cytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory activity.J Virol,2008,82(6):3078-3089.
• [21]Salmon P,Trono D.Production and titration of lentiviral vectors.Curr Protoc Neurosci,2006,Chapter4:Unit4.21.
• [22]Wong LF,Goodhead L,Prat C,et al.Lentivirus-mediated genetransfer to the central nervous system:therapeutic and research applications.Hum Gene Ther,2006,17(1):1-9.
• [23]Sinn PL,Burnight ER,Hickey MA,et al.Persistent gene expres-sion in mouse nasal epithelia following feline immunodeficiency virus-based vector gene transfer.J Virol,2005,79(20):12818-12827.
• [24]McKay T,Patel M,Pickles RJ,et al.Influenza M2envelope pro-tein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors.Gene Ther,2006,13(8):715-724.
• [25]Haynes JR,Dokken L,Wiley JA,et al.Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge.Vaccine,2009,27(4):530-541.
• [26]石艳春,梁浩,旭日干.融合表达IL-2和EGFP逆转录病毒载体的构建.中国生物制品学杂志,2006,19(1):1-4.
• [27]Fu Y,Luo L,Luo N,et al.Proinflammatory cytokine production and insulin sensitivity regulated by overexpression of resistin in3T3-L1adipocytes.Nutr Metab(Lond),2006,3(1):28-37.
• [28]Virk MS,Conduah A,Park SH,et al.Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2expression on the quality of bone repair in a rat femoral defect model.Bone,2008,42(5):921-931.
• [29]Lillico SG,Sherman A,McGrew MJ,et al.Oviduct-specific ex-pression of two therapeutic proteins in transgenic hens.Proc Natl Acad Sci USA.2007,104(6):1771-1776.
• [30]Pestina TI,Hargrove PW,Jay D,et al.Correction of murine sick-le cell disease using gamma-globin lentiviral vectors to mediate high-level expression of fetal hemoglobin.Mol Ther,2008,2.
• [31]Niemann H,Kues WA.Transgenic farm animals:an update.Re-prod Fertil Dev,2007,19(6):762-770.
• [32]Park F.Lentiviral vectors:are they the future of animal transgen-esis.Physiol Genomics,2007,31(2):159-173.
• [33]Baba K,Goto-Koshino Y,Mizukoshi F,et al.Inhibition of the replication of feline immunodeficiency virus by lentiviral vector-mediated RNA interference in feline cell lines.J Vet Med Sci,2008,70(8):777-783.
• [34]Joo KI,Wang P.Visualization of targeted transduction by engi-neered lentiviral vectors.Gene Ther,2008,15(20):1384-1396.
• [35]Semple-Rowland SL,Eccles KS,Humberstone EJ.Targeted ex-pression of two proteins in neural retina using self-inactivating,insulated lentiviral vectors carrying two internal independent promoters.Mol Vis,2007,13:2001-2011.
• [36]Hargrove PW,Kepes S,Hanawa H,et al.Globin lentiviral vector insertions can perturb the expression of endogenous genes in be-ta-thalassemic hematopoietic cells.Mol Ther,2008,16(3):525-533.
• [37]Bauer G,Dao MA,Case SS,et al.In vivo biosafety model to as-sess the risk of adverse events from retroviral and lentiviral vec-tors.Mol Ther,2008,16(7):1308-1315.